These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19341914)

  • 21. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
    Bian Y; Rong Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):28-37. PubMed ID: 21689051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemoglobin tetramers stabilized with polyaspirins.
    Bucci E; Fronticelli C; Razynska A; Militello V; Koehler R; Urbaitis B
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):243-52. PubMed ID: 1391438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoglobin solutions.
    Waschke KF; Frietsch T; Quintel M; Lenz C; Rebel A
    Acta Anaesthesiol Scand Suppl; 1997; 111():259-63. PubMed ID: 9421037
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the effectiveness of artificial oxygen carrier on the hemoglobin base in blood loss replacement in dogs].
    Litvinenko IuA; Kolonina IR; Sokolov AV; Gorbunova NA
    Gematol Transfuziol; 1991 Aug; 36(8):16-8. PubMed ID: 1752403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.
    Bian YZ; Guo C; Chang TM
    Artif Cells Nanomed Biotechnol; 2016; 44(1):41-7. PubMed ID: 26613265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.
    Bian Y; Chang TM
    Artif Cells Nanomed Biotechnol; 2015 Feb; 43(1):1-9. PubMed ID: 25297052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-oximetry interference by hemoglobin-based blood substitutes.
    Ali AA; Ali GS; Steinke JM; Shepherd AP
    Anesth Analg; 2001 Apr; 92(4):863-9. PubMed ID: 11273915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-linked stroma-free polyhemoglobin as a potential blood substitute.
    Keipert P; Minkowitz J; Chang TM
    Int J Artif Organs; 1982 Nov; 5(6):383-5. PubMed ID: 7160935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.
    Gao W; Bian Y; Chang TM
    Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):232-9. PubMed ID: 23336597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
    Chang TM
    Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanobiotechnological basis of an oxygen carrier with enhanced carbonic anhydrase for CO
    Bian Y; Chang TMS
    Front Bioeng Biotechnol; 2023; 11():1188399. PubMed ID: 37122869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not blood simple.
    Stokstad E
    Science; 2002 Feb; 295(5557):1003. PubMed ID: 11834812
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis of a hemoglobin polymer containing antioxidant enzymes using complementary chemistry of maleimides and sulfhydryls.
    Tarasov E; Blaszak MM; LaMarre JM; Olsen KW
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):31-43. PubMed ID: 17364469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up.
    Beissinger RL; Farmer MC; Gossage JL
    ASAIO Trans; 1986; 32(1):58-63. PubMed ID: 3778774
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
    Smani Y; Labrude P; Vigneron C; Faivre B
    Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
    D'Agnillo F; Chang TM
    Nat Biotechnol; 1998 Jul; 16(7):667-71. PubMed ID: 9661202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial Oxygen Carriers: Exactly How Close Are We to an Ultimate Product?
    Simoni J
    Artif Organs; 2017 Apr; 41(4):316-318. PubMed ID: 28397406
    [No Abstract]   [Full Text] [Related]  

  • 38. Modified hemoglobin blood substitutes: present status and future perspectives.
    Chang TM
    Biotechnol Annu Rev; 1998; 4():75-112. PubMed ID: 9890139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemoglobin solution--from tetramer to polymer.
    Moss GS; Gould SA; Sehgal LR; Sehgal HL; Rosen AL
    Surgery; 1984 Mar; 95(3):249-55. PubMed ID: 6701780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview.
    Chang TM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):159-79. PubMed ID: 1391433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.